Literature DB >> 11387918

Lifestyle drugs: issues for debate.

J Lexchin1.   

Abstract

Keywords:  Professional Patient Relationship

Mesh:

Substances:

Year:  2001        PMID: 11387918      PMCID: PMC81072     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  How far should indications for growth hormone treatment expand?

Authors: 
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

2.  Access to essential drugs in poor countries: a lost battle?

Authors:  B Pécoul; P Chirac; P Trouiller; J Pinel
Journal:  JAMA       Date:  1999-01-27       Impact factor: 56.272

3.  FDA approves tuberculosis drug.

Authors:  D Josefson
Journal:  BMJ       Date:  1998-07-04

4.  Funding medical and health-related research in the public interest.

Authors:  P A Baird
Journal:  CMAJ       Date:  1996-08-01       Impact factor: 8.262

Review 5.  SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

Authors:  A L Montejo-González; G Llorca; J A Izquierdo; A Ledesma; M Bousoño; A Calcedo; J L Carrasco; J Ciudad; E Daniel; J De la Gandara; J Derecho; M Franco; M J Gomez; J A Macias; T Martin; V Perez; J M Sanchez; S Sanchez; E Vicens
Journal:  J Sex Marital Ther       Date:  1997

6.  Growth hormone therapy and the short end of the stick.

Authors:  M M Grumbach
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

7.  Sex differences in the use of mood-modifying drugs: an explanatory model.

Authors:  R Cooperstock
Journal:  J Health Soc Behav       Date:  1971-09

8.  Clinical decision-making in the evaluation and treatment of insomnia.

Authors:  D E Everitt; J Avorn; M W Baker
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

  8 in total
  12 in total

1.  Lifestyle drugs.

Authors:  A R Miller
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

2.  Lifestyle drugs, mood, behaviour and cognition.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2003-03       Impact factor: 6.186

3.  How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960.

Authors:  Elizabeth Siegel Watkins
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

4.  Asymptotic medicine.

Authors:  Karmen Loncarek
Journal:  Croat Med J       Date:  2009-02       Impact factor: 1.351

5.  More Is Not Always Better: Intuitions About Effective Public Policy Can Lead to Unintended Consequences.

Authors:  Ellen Peters; William Klein; Annette Kaufman; Louise Meilleur; Anna Dixon
Journal:  Soc Issues Policy Rev       Date:  2013-01-01

6.  How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Authors:  Barbara Mintzes; Morris L Barer; Richard L Kravitz; Ken Bassett; Joel Lexchin; Arminée Kazanjian; Robert G Evans; Richard Pan; Stephen A Marion
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

7.  Erectile dysfunction among diabetic patients in saudi arabia: a hospital-based primary care study.

Authors:  Yousef A Al-Turki
Journal:  J Family Community Med       Date:  2007-01

8.  A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

9.  Lifestyle drugs: concept and impact on society.

Authors:  S Z Rahman; V Gupta; Anupama Sukhlecha; Y Khunte
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

Review 10.  The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA.

Authors:  Charles Baum; Katherine Andino; Eric Wittbrodt; Shelley Stewart; Keith Szymanski; Robin Turpin
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.